LUCA SCIENCE

luca-science-logo

LUCA Science develops innovative treatments intended for mitochondrial and related diseases.

#People #Financial #Website #More

LUCA SCIENCE

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
2018-12-01

Address:
Tokyo, Tokyo, Japan

Country:
Japan

Website Url:
http://www.luca-science.com

Total Employee:
1+

Status:
Active

Total Funding:
39 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Tag Manager Content Delivery Network Global Site Tag Euro Organization Schema Japanese Yen



Current Advisors List

not_available_image

Shuntaro Kodama Board Member @ LUCA Science
Board_member

not_available_image

Philippe Fauchet Board Member @ LUCA Science
Board_member

tai-harada_image

Tai Harada Board Member @ LUCA Science
Board_member

Current Employees Featured

masashi-suganuma_image

Masashi Suganuma
Masashi Suganuma Founder & Chief Scientific Officer @ LUCA Science
Founder & Chief Scientific Officer

tomoaki-shinohara_image

Tomoaki Shinohara
Tomoaki Shinohara Chief Operating Officer @ LUCA Science
Chief Operating Officer
2019-04-01

rick-c-tsai_image

Rick C. Tsai
Rick C. Tsai Chief Executive Officer @ LUCA Science
Chief Executive Officer

Founder


masashi-suganuma_image

Masashi Suganuma

Investors List

smbc-venture-capital_image

SMBC Venture Capital

SMBC Venture Capital investment in Series B - LUCA Science

ncb-ventures_image

NCB Ventures

NCB Ventures investment in Series B - LUCA Science

fast-track-initiative_image

Fast Track Initiative, Inc.

Fast Track Initiative, Inc. investment in Series B - LUCA Science

asahi-kasei-ac3b_image

Asahi Kasei Pharma

Asahi Kasei Pharma investment in Series B - LUCA Science

nissay-capital_image

Nissay Capital

Nissay Capital investment in Series B - LUCA Science

nippon-venture-capital_image

Nippon Venture Capital

Nippon Venture Capital investment in Series B - LUCA Science

dci-partners_image

DCI Partners

DCI Partners investment in Series B - LUCA Science

4bio-capital-partners_image

4BIO Capital

4BIO Capital investment in Series B - LUCA Science

qb-capital_image

QB Capital

QB Capital investment in Series B - LUCA Science

remiges-ventures_image

Remiges Ventures

Remiges Ventures investment in Series B - LUCA Science

Official Site Inspections

http://www.luca-science.com Semrush global rank: 4.38 M Semrush visits lastest month: 2.56 K

  • Host name: 198.49.23.145
  • IP address: 198.49.23.145
  • Location: New York United States
  • Latitude: 40.7157
  • Longitude: -74
  • Metro Code: 501
  • Timezone: America/New_York
  • Postal: 10013

Loading ...

More informations about "LUCA Science"

LUCA Science Inc.

We are a pre-clinical stage biotechnology company focused on developing functional mitochondria as therapeutic agents, an emerging platform to treat damaged tissues and …See details»

About us - LUCA Science Inc.

LUCA Science is developing an innovative platform of highly functional mitochondria using our proprietary iMIT technologies. By providing intact and functional mitochondria to the affected tissues, we could improve …See details»

LUCA Science - Crunchbase Company Profile & Funding

LUCA Science is at the forefront of a new kind of mitochondrial therapy that aims to restore cellular bioenergetics in malfunctioning or damaged tissues and organs. Using our patented iMIT technology, LUCA Science is creating a novel …See details»

LUCA Science Company Profile 2024: Valuation, …

Operator of a biotechnology platform intended to develop functional mitochondria as therapeutic agents to treat damaged tissues and organs.See details»

LUCA Science Inc. - J-Startup

LUCA Science is a preclinical stage biopharmaceutical company pioneering a new class of mitochondrial therapy to restore cellular bioenergetics. Mitochondria are the power plants in …See details»

LUCA Science Inc. - LinkedIn

Enabling functional mitochondria as therapeutic agents. | We are a pre-clinical stage biotechnology company focused on developing functional mitochondria as therapeutic agents, an emerging platform...See details»

Luca Science Inc. - MitoWorld

Enabling functional mitochondria as therapeutic agents to restore energy for life. Website: https://www.luca-science.com/See details»

Our Platform - LUCA Science Inc.

We are building a mitochondrial engineering technology platform which can enhance the quality and function of mitochondria all the way from its cell source to the target site of delivery in the future. Therapeutic Areas & Collaborations .See details»

LUCA Science - Remiges Ventures

Apr 20, 2020 · Luca Science is a private biotechnology company headquartered in Japan. Being a spin out of Koinobori Associate a non-profit organization focused on mitochondrial diseases in …See details»

LUCA Science - Funding, Financials, Valuation & Investors

LUCA Science develops innovative treatments intended for mitochondrial and related diseases.See details»

LUCA Science Announces $9.8 Million Series A …

Sep 1, 2020 · TOKYO-- ( BUSINESS WIRE )--LUCA Science, a company developing functional mitochondria as therapeutic agents, an emerging platform to treat damaged tissues and organs, today announced the closing of...See details»

Luca Science Company Profile - Office Locations, Competitors

LUCA Science is a biotechnology company that develops functional mitochondrial therapy to restore cellular bioenergetics in damaged tissues and organs. Its technology restores the …See details»

LUCA Science - Contacts, Employees, Board Members

LUCA Science has 3 current employee profiles, including Founder & Chief Scientific Officer Masashi Suganuma. LUCA Science has 3 board members and advisors, including Shuntaro …See details»

Notice on Appointment of COO - LUCA Science Inc.

Mar 1, 2024 · LUCA Science Inc. (hereinafter referred to as "LUCA") is pleased to announce the appointment of Mr. Stig Ogata as Chief Operating Officer (COO). Mr. Ogata brings with him 30 …See details»

LUCA Science Announces $9.8 Million Series A Financing to

Sep 1, 2020 · LUCA Science, a company developing functional mitochondria as therapeutic agents, an emerging platform to treat damaged tissues and organs, today announced the …See details»

LUCA Science Announces the Opening of a New Subsidiary in the …

Apr 7, 2021 · TOKYO-- ( BUSINESS WIRE )--LUCA Science (Tokyo, Japan), a biotechnology company pioneering a novel class of mitochondrial therapeutics has announced the expansion …See details»

A tale of two cultures: How L. Luca Cavalli-Sforza bridged the gap ...

Nov 18, 2024 · This article retraces the career of geneticist L. Luca Cavalli-Sforza, from his days as a student researcher to his tenure as a Stanford University professor, and beyond. ... These …See details»

Announcement of New CEO — LUCA Science Inc.

Jul 1, 2020 · LUCA Science announced that Dr. Rick C. Tsai will become the new Chief Executive Officer (CEO) of the company, effective July 1, 2020.See details»

LUCA Science Inc. - LinkedIn

LUCA Science Inc. | 467 followers on LinkedIn. Enabling functional mitochondria as therapeutic agents. | We are a pre-clinical stage biotechnology company focused on developing functional...See details»

The human social cognitive network contains multiple regions

6 days ago · The ability to reason about another person’s intentions and beliefs—i.e., to form a “theory of mind” (ToM)—is an important aspect of social cognition that assists the navigation of …See details»

linkstock.net © 2022. All rights reserved